ArticleJournal of experimental & clinical cancer research : CR2024

CDKL1 potentiates the antitumor efficacy of radioimmunotherapy by binding to transcription factor YBX1 and blocking PD-L1 expression in lung cancer.

Zixuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.